Company Name, Ticker, Customers, else..

Filana Therapeutics Inc (NASDAQ: FLNA)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Filana Therapeutics Inc 's

Name: Filana Therapeutics Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FLNA Sales vs. its Competitors Q1 2026

Comparing the current results to its competitors, Filana Therapeutics Inc reported Revenue decrease in the 1 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 11.11 %, recorded in the same quarter.

• List of FLNA Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Filana Therapeutics Inc , slower than the average decrease reported by the company's competitors of -79.45 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -79.45 %

<< FLNA Stock Performance Comparisons

<< See the full list of FLNA competitors

*Market share is calculated based on total revenue.

FLNA's Stock Performance relative to its Competitors

Publicly Traded Peers of Filana Therapeutics Inc

Damora Therapeutics Inc
Share Performance

+13.75%

This Quarter

Damora Therapeutics Inc

Profile

The company is a preclinical stage biotechnology firm focused on developing product candidates for various diseases.

More about Damora Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 1,729.613 mill.	$ - mill.	$ -62.116 mill.

Leonabio Inc
Share Performance

+9.06%

30 Days

Leonabio Inc

Profile

The company develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).

More about Leonabio Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 193.300 mill.	$ - mill.	$ -141.455 mill.

Lipocine Inc
Share Performance

-72.71%

This Year

Lipocine Inc

Profile

Lipocine Inc is a pharmaceutical company focused on developing oral drug delivery systems for hormone therapeutics. Their business model involves conducting research and development to create innovative products that address unmet medical needs in areas such as testosterone replacement therapy and hypogonadism. The company aims to commercialize these proprietary drug candidates and collaborate with industry partners to enhance their potential reach and impact.

More about Lipocine Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 17.939 mill.	$ 1.569 mill.	$ -11.851 mill.

Medicure Inc
Share Performance

0.00%

Over The Past 5 Days

Medicure Inc

Profile

Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.

More about Medicure Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ - mill.	$ 22.103 mill.	$ -5.436 mill.

Mereo Biopharma Group Plc
Share Performance

-18.28%

This Quarter

Mereo Biopharma Group Plc

Profile

Mereo Biopharma Group Plc's business model focuses on the development and commercialization of innovative therapeutics for rare diseases.

More about Mereo Biopharma Group Plc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 45.078 mill.	$ - mill.	$ -35.710 mill.

58 more competitors available

Sources: Filana Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 1, 2026 7:47 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Filana Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.